INTERLEUKIN-17 IS A NEW TARGET FOR ANTI-CYTOKINE THERAPY OF IMMUNE INFLAMMATORY RHEUMATIC DISEASES

by Evgeny Lvovich Nasonov, L N Denisov, M L Stanislav
Published 2013-12-01

Prospects of pharmacotherapy for rheumatoid arthritis: Monoclonal antibodies

by Evgeny Lvovich Nasonov, L N Denisov, M L Stanislav, A E Ilyina
Published 2012-06-01

Ustekinumab is a new drug to treat psoriasis and psoriatic arthritis

by Yuliya Leonidovna Korsakova, M L Stanislav, L N Denisov, E L Nasonov
Published 2013-04-01

BELIMUMAB: ADVANCES IN DRUG THERAPY FOR SYSTEMIC LUPUS ERYTHEMATOSUS

by Evgeny Lvovich Nasonov, T M Reshetnyak, L N Denisov, M L Stanislav, S K Solovyov
Published 2012-10-01

INTERLEIKIN 1 KAK MEDIATOR VOSPALENIYa I TERAPEVTIChESKAYa MIShEN''

by A. E. Il'ina, M. L. Stanislav, L. N. Denisov, E. L. Nasonov
Published 2011-06-01

ANTI-INTERLEUKIN-17 MONOCLONAL ANTIBODY FOR THE TREATMENT OF ANKYLOSING SPONDYLITIS: RESULTS OF ANALYSIS OF A RUSSIAN PATIENT GROUP FROM THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTR...

by Sh. F. Erdes, L. N. Denisov, A. L. Maslyansky, O. B. Ershova, M. L. Stanislav, T. S. Salnikova, N. V. Izmozherova, O. M. Lesnyak
Published 2017-03-01

184. OPREDELENIE IMMUNOGLOBULINOV K VAZOAKTIVNYM PEPTIDAM I ANGIOTENZINPREVRAShchAYuShchEMU FERMENTU U BOL'NYKh REVMATOIDNYM ARTRITOM

by M L Stanislav, M A Myagkova, T V Abramenko, I. P. Kiselev, O. A. Kost, I I Nikol'skaya, E V Garats, R M Balabanova
Published 2000-08-01

Expirence of the using of Stopartroz in patients with knee osteoarthritis

by L N Denisov, J G Slesina, M S Petrova, O F Ryabitseva, I V Kudryavtseva, G S Arhangelskaya, I A Sborovskaya, L P Filimonova, M L Stanislav, E Y Panasyuk, E P Sharapova
Published 2007-06-01

Use of the interleukin-17A inhibitor secukinumab in psoriatic arthritis: a subanalysis of the Russian population in the international randomized clinical trials FUTURE 1 and FUTURE...

by T. V. Korotaeva, E. G. Zotkin, O. B. Nesmeyanova, N. N. Vezikova, O. B. Ershova, N. V. Izmozzherova, M. S. Petrova, A. A. Kastanyan, S. P. Yakupova, A. S. Agafina, M. L. Stanislav, E. A. Novoderezhkina, E. L. Nasonov, P. J. Mease
Published 2017-04-01

LONG-TERM SAFETY AND EFFICACY OF TOCILIZUMAB IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS OF MODERATE OR HIGH ACTIVITY (RESULTS OF PHASE III MULTICENTER EXTENSION CLINICAL STUDY ML2...

by E. L. Nasonov, M. L. Stanislav, V. I. Mazurov, T. M. Chernykh, V. N. Sorotskaya, T. S. Salnikova, R. S. Saikovsky, O. V. Reshet’ko, T. A. Popova, E. I. Shmidt, V. P. Tyurin, N. P. Shilkina, I. N. Bokarev, M. Z. Kanevskaya, S. S. Yakushin
Published 2018-07-01

Efficacy and safety of sarilumab in combination with methotrexate in patients with active rheumatoid arthritis and inadequate effect of methotrexate monotherapy (results of phase I...

by E. L. Nasonov, M. L. Stanislav, T. A. Raskina, G. V. Kuropatkin, I. V. Shirinsky, A. P. Rebrov, N. A. Shostak, B. A. Alikhanov, E. N. Ushakov, R. G. Kamalova, S. A. Smakotina, V. I. Simanenkov, A. S. Pavsun, I. I. Zaharjan, S. S. Yakushin, M. Yu. Sandin
Published 2019-05-01

New treatment possibilities for rheumatoid arthritis: the Russian experience in using certolizumab pegol

by Dmitry Evgenyevich Karateev, E L Nasonov, L N Denisov, M L Stanislav, E Yu Panasyuk, I A Andrianova, V I Mazurov, E S Zhugrova, Yu P Uspensky, L N Belousova, E P Ilivanova, G K Matsiyevskaya, G P Aurtyunov, K A Lytkina, R S Saikovsky, V N Ardashev, E V Zhilyaev, N I Korshunov
Published 2012-04-01

Use of monoclonal antibodies to tumor necrosis factor (the drug remicade) in rheumatoid arthritis: pilot results

by G V Lukina, Ya A Sigidin, N V Chichasova, R M Balabanova, A G Belenky, G R Imametdinova, V G Barskova, A G Bochkova, D A Gukasyan, О N Egorova, D E Karateev, I R Kolosova, E Yu Loginova, E Yu Pudovkina, M L Stanislav, L A Taukumova, T P Fedina, E L Nasonov
Published 2003-05-01